Atlas Trials

Evaluation of Efficacy and Safety of Rituximab With Mycophenolate Mofetil in Patients With Interstitial Lung Diseases

Clinical trial NCT02990286 · COMPLETED

Trial details

NCT number
NCT02990286
Sponsor
University Hospital, Tours
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Lung Disease, Interstitial
Start date
2017-01-20
Primary completion
2019-07-24
Enrollment
122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.